Literature DB >> 23231510

Energy restriction: stepping stones towards cancer therapy.

Hany A Omar, Lisa Berman-Booty, Jing-Ru Weng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23231510     DOI： 10.2217/fon.12.142

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  4 in total

1.  OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro.

Authors:  El-shaimaa A Arafa; Ahmed H Abdelazeem; Hany H Arab; Hany A Omar
Journal:  Acta Pharmacol Sin       Date:  2014-01-27       Impact factor: 6.150

2.  Resveratrol ameliorates high glucose and high-fat/sucrose diet-induced vascular hyperpermeability involving Cav-1/eNOS regulation.

Authors:  Xiao Lin Peng; Wei Qu; Lin Zhi Wang; Bin Qing Huang; Chen Jiang Ying; Xiu Fa Sun; Li Ping Hao
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

Review 3.  Tumor bioenergetics: an emerging avenue for cancer metabolism targeted therapy.

Authors:  Hyun Jung Kee; Jae-Ho Cheong
Journal:  BMB Rep       Date:  2014-03       Impact factor: 4.778

4.  Advances in glucose metabolism research in colorectal cancer.

Authors:  Sitian Fang; Xiao Fang
Journal:  Biomed Rep       Date:  2016-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.